skip to Main Content
 

AIM round-up: Aura Energy, Image Scan, Blackbird

*

Having taken a pause for breath on Friday, London’s AIM market continued its sell off as the new trading week got underway. Major indices worldwide seem to be finding some support, but the overriding risk-off mindset appears to be taking a toll on the junior board. By the bell it was down more than ten points at 1284.76.

  • Aura Energy +36%
  • Image Scan +29%
  • MyHealthChecked -25%
  • ITM Power -12%
  • Blackbird -10%

Aura Energy [LON:AURA] added another 36% today, extending the run of gains which have been seen since the start of the month. Shares have quadrupled in value since September 1st with that resource upgrade at the very end of August appearing to be the catalyst here. The question has to be just how long such a gradual run up can be sustained for


A trading update from Image Scan [LON:IGE] helped propel the specialist X-ray imaging company to second place on the board, adding some 29% by the close. The company outlined three orders which had been placed and because these will be fulfilled in the current financial year, previous guidance of a £200,000 loss for the 12 months to 30th September has been upgraded to a £2.9m trading profit.

MyHealthChecked [LON:MHC] was the day’s worst performer, but with government suggesting they will soon abandon PCR testing for travellers returning from overseas, this is perhaps no surprise. Volumes were notably higher than has been seen in the past and even with a 7% bid/offer spread, the losses – down 25% by the bell – are notable.

ITM Power [LON:ITM] made it onto our radar today after notching up some significant losses. Shares sat some 12% down by the closing bell as investors were once again underwhelmed by results published from the company. Despite a growing order book and list of tenders, the company is yet to turn a profit.

A notable mention for broadcast technology play Blackbird [LON:BIRD] as they came up last week. Shares slipped 10% today off the back of interim results. Revenues rose, but so did costs and this in turn pushed out losses to almost £1.2m, up from £940k for the same period last year.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

Read our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

Listen to our latest podcast episodes

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
FP Markets
IG
Pepperstone
WisdomTree
CME Group
Back To Top